HopeStage
Back to all studies
SuspendedNCT01794559

Study to Evaluate the Safety and Efficacy of PEER Interactive Versus Treatment as Usual in Subjects With a Primary Diagnosis of Depression

Device studyAges 18–65United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Bethesda and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateMarch 1, 2013
Recruitment status
Suspended
Enrollment listed in the registry
1,922
Sponsor
MYnd Analytics
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT01794559
Official title
Show the full official title

A Prospective, Double Blind, Randomized, Multicenter Study to Evaluate the Utility, Safety, and Efficacy of Using PEER Interactive to Inform the Prescription of Medications to Patients With a Primary Diagnosis of a Depressive Disorder Versus Treatment as Usual.

Recruitment & locations

Suspended

Bethesda · Fort Belvoir

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is MYnd Analytics.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as suspended.

Want to explore more studies?

Explore studies